Valgene Incorporated dba Cape Drugs: Drug Recall
Recall #D-0284-2022 · 12/03/2021
Class II: Risk
Recall Details
- Recall Number
- D-0284-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Valgene Incorporated dba Cape Drugs
- Status
- Terminated
- Date Initiated
- 12/03/2021
- Location
- Annapolis, MD, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12 vials
Reason for Recall
Lack of Processing Controls
Product Description
B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
Distribution Pattern
Maryland Only
Other Recalls by Valgene Incorporated dba Cape Drugs
- Class II: Risk 12/03/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.